These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 9353368)
1. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria. Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a new milrinone analogue. Dorigo P; Fraccarollo D; Santostasi G; Gaion RM; Maragno I; Floreani M; Carpenedo F; Jester M; Mosti L; Schenone P Farmaco; 1994 Jan; 49(1):19-23. PubMed ID: 8185745 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013 [TBL] [Abstract][Full Text] [Related]
4. An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria. Dorigo P; Gaion RM; Belluco P; Mosti L; Borea PA; Maragno I Br J Pharmacol; 1991 Dec; 104(4):867-72. PubMed ID: 1810600 [TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Sep; 38(9):1287-92. PubMed ID: 2906245 [TBL] [Abstract][Full Text] [Related]
7. Effect of milrinone on ethanol and halothane induced cardiodepression. Neira S; Penna M Acta Physiol Pharmacol Latinoam; 1988; 38(2):193-211. PubMed ID: 2847492 [TBL] [Abstract][Full Text] [Related]
8. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity. Heber D; Heers C; Ravens U Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456 [TBL] [Abstract][Full Text] [Related]
9. Effects of the triazolopyrimidine trapidil on force of contraction, beating frequency and phosphodiesterase I--IV activity in guinea-pig hearts. Bethke T; Mehl H; Meyer W; Schmitz W; Scholz H; Thomas K; Wenzlaff H Arzneimittelforschung; 1991 May; 41(5):461-8. PubMed ID: 1716891 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
11. New inotropic agents: milrinone analogs. Dorigo P; Fraccarollo D; Gaion RM; Santostasi G; Borea PA; Floreani M; Mosti L; Maragno I Gen Pharmacol; 1997 May; 28(5):781-8. PubMed ID: 9184820 [TBL] [Abstract][Full Text] [Related]
12. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase. Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related]
14. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives]. Hagen V; Hagen A; Krause EG; Klauschenz E Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril. Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of saterinone and milrinone in the isolated guinea pig myocardium. Iven H; Brasch H; Armah BI Arzneimittelforschung; 1988 Sep; 38(9):1298-302. PubMed ID: 2906246 [TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor. Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731 [TBL] [Abstract][Full Text] [Related]
18. [Milrinone decreases the positive inotropic response of heart muscle to izadrin]. Bardamova IB; Afanas'ev SA Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778 [TBL] [Abstract][Full Text] [Related]
19. Myocardial actions of milrinone: characterization of its mechanism of action. Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746 [TBL] [Abstract][Full Text] [Related]
20. Lack of stereoselectivity in the inotropic and phosphodiesterase inhibitory effects of saterinone enantiomers. Armah BI; Muster D; Raap A; Brückner R; Graziadei I Arzneimittelforschung; 1989 Nov; 39(11):1384-92. PubMed ID: 2559738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]